Industry Session by Genomenon: Curating the Human Genome to Advance Early Identification of Rare Diseases*

The recording of this session is now available. Please view in the Content tab. 

Title: Curating the Human Genome to Advance Early Identification of Rare Diseases: Meeting the Needs of Newborn Sequencing

The most critical challenge to making newborn sequencing a reality is genomic variant interpretation. Current approaches of interpreting variants one-by-one are impractical when it comes to screening a mostly healthy newborn population with whole genome sequencing. A radically different approach is needed to hit the time, cost, and throughput objectives for newborn screening of whole genomes. 

In this live discussion and demonstration, industry experts will show how a comprehensive, pre-curated list of causative variants can be used to rapidly screen for rare diseases and how a unique combination of AI-driven genomic technology and expert scientific review has emerged as the best and most viable way to curate the entire human genome. 

The speakers will describe Genomenon’s contributions to the BeginNGS™ initiative at the Rady Children’s Institute for Genomic Medicine, and how pre-curated classifications for every variant found in the scientific literature will be used to screen against over 450 genetic diseases at birth. They will then show how variant classification and supporting evidence is presented in the Mastermind® Genomic Search Engine to enable rapid assessment and identification of newborns at risk for developing a rare disease. 

The session will include a Q&A session around the implications of this technology on the future of rare disease screening and diagnosis. 

You will learn: 

• How a unique balance of AI and expert review creates a solid foundation of high-quality evidence to understand the genetic basis of a targeted disease 
• How the integration of data from the scientific literature with commonly used variant databases like ClinVar streamline accurate and timely diagnoses for patients 
• How this approach is being used to comprehensively access and classify every variant in the human genome, starting with newborn sequencing applications 

Speakers:

• Mark Kiel, MD, PhD, Chief Scientific Officer, Genomenon 
• Brittnee Jones, PhD, Director of Customer Success, Genomenon

*By registering for and attending this session, you consent to share your contact information with the sponsor of this session. Please view the disclaimer tab for more information.

By clicking on the registration and event links for this session, please recognize you are being directed to a webinar or registration form from the sponsoring company where you may be asked to submit your contact information in order to attend the sponsored session. By completing the registration form and/or by attending an industry event, your information will be collected by the sponsoring company, and you may be contacted regarding your session attendance and future interest in the company’s products or services. 

 
The hosting of any promotional material, links, or sessions on the ASHG website or the ASHG Learning Center does not indicate an endorsement by ASHG of the products or services promoted, the company, or the claims made. ASHG does not sell, rent, or share member contact information. Any information you choose to share will be shared with the company directly, and you may request to be removed from their mailing lists at any time.